Antimicrobials solution company Primel launches

The launch of Primel, a company focused on providing antimicrobial solutions for the patient care sector, was announced at the Infection Prevention Society (IPS) conference. Primel works closely with its strategic partner BioInteractions, the research and development company specialising in biomaterial technologies for the medical device industry.

Building on TridAnt, Primel was founded to advance antimicrobial protection in all patient care environments. TridAnt, developed by BioInteractions, is a coating technology for medical devices that incorporates active and passive components to create the first truly non-leaching, effective, safe, and durable antimicrobial coating which lasts for up to 365 days, and helps to save lives and time needed for medical treatments. The intended result is the improvement in well-being and reduction in risks to both patients and professionals.

Regular washing of hands reduces the concentration of microbes on the skin but does not eliminate all of them. Every time two surfaces come into contact an exchange of microbes takes place. Primel, with the help of TridAnt, can keep hands protected even after they stop sanitising as well as break that cycle in every instance, they touch a surface. Using Kill-On-Touch Technology, the user is able to disinfect the surface they touch rather than transmit germs to it. The continued research of the team behind TridAnt has resulted in a skin-safe antimicrobial technology that stays on the skin for two days and ensures the user is consistently protected.

Arjun Luthra, chairman and CEO of Primel, said: “The launch of Primel represents a paradigm shift in the way we approach patient care. TridAnt Touch Clean Technology stays on the skin for 48 hours, allowing for the first time, all care personnel to spread protection with their touch. TridAnt is the only infection prevention infrastructure which consistently protects both the individual and the surfaces they touch.”

Frequently touched devices and surfaces in and around patient sites in the critical care environment are more likely to be heavily contaminated with microbial soil. There also appears to be a quantitative association between the number of times a surface is handled and the amount of aerobic microbial soil retrieved from that surface. During an average 12-hour shift nurses touch a variety of surfaces 821 times. The majority (58%) of these touchpoints are with or in close proximity of patients. Treating hands with the TridAnt coating, in addition to regular washing, cuts the risk of cross contamination.